Naloxone Hydrochloride Injection — Class I drug recall D-0906-2018
Terminated recall by HOSPIRA INC, LAKE FOREST, reported 2018-06-13, distributed nationwide. Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
| Recall number | D-0906-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | HOSPIRA INC, LAKE FOREST, LAKE FOREST, IL, United States |
| Recall initiated | 2018-06-04 |
| Classified | 2018-07-02 |
| Reported by FDA | 2018-06-13 |
| Terminated | 2020-03-27 |
| Distributed | Nationwide (US) |
| Quantity | 164,860 syringes |
| Reason classes | specification failure |
| NDC | 00409-1782, 00409-1782-03, 00409-1782-69 |
| Expiration dates | 2018-12-01, 2019-04-01 |
Product
Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL Carpuject Single-use cartridge syringe, Single unit (NDC 0409-1782-03) and 10 count box (NDC 0409-1782-69), Rx Only, Hospira Inc., Lake Forest, IL
Reason for recall
Presence of Particulate Matter; Potential for particulate matter on the syringe plunger.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0906-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.